An Open Study to Investigate the Safety & Efficacy of Optivate® in

See also
Status	Clinical Trial	Phase
Completed	`NCT05082116` - Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10)	Phase 3
Completed	`NCT03660774` - A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Active, not recruiting	`NCT04675541` - Register of Patients With haEmophilia A tReated With Afstyla®
Completed	`NCT01949792` - A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors	Phase 1
Completed	`NCT01205724` - Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A	Phase 1
Completed	`NCT01562587` - Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State	Phase 1
Completed	`NCT02246868` - An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.	Phase 3
Completed	`NCT01493778` - Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A	Phase 3
Completed	`NCT02490787` - Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects	Phase 1
Completed	`NCT02920398` - A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A	Phase 1
Completed	`NCT03276130` - Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B
Completed	`NCT00984126` - Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015	Phase 3
Completed	`NCT01228669` - Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B	Phase 1
Enrolling by invitation	`NCT04574076` - A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®
Completed	`NCT01988532` - Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia	N/A
Completed	`NCT01436825` - Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients	N/A
Completed	`NCT01234545` - Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors	N/A
Completed	`NCT00245297` - Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.	Phase 2
Completed	`NCT02941354` - Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A	Phase 1
Recruiting	`NCT05621746` - An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct

NCT number	NCT02250482
Study type	Interventional
Source	Bio Products Laboratory
Contact
Status	Completed
Phase	Phase 3
Start date	November 2001

An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms